ICICI Prudential Mutual Fund
| Instrument | Industry / rating | Quantity | Value (₹ Cr) | % to NAV |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd.SUNPHARMA | Pharmaceuticals & Biotechnology | 2.16 L | 42.84 | 18.08% |
| Divi's Laboratories Ltd.DIVISLAB | Pharmaceuticals & Biotechnology | 25,904 | 24.52 | 10.35% |
| Apollo Hospitals Enterprise Ltd.APOLLOHOSP | Healthcare Services | 20,976 | 18.67 | 7.88% |
| Cipla Ltd.CIPLA | Pharmaceuticals & Biotechnology | 1.15 L | 16.16 | 6.82% |
| MAX Healthcare Institute LtdMAXHEALTH | Healthcare Services | 1.52 L | 15.81 | 6.67% |
| Laurus Labs Ltd.LAURUSLABS | Pharmaceuticals & Biotechnology | 79,305 | 15.19 | 6.41% |
| Torrent Pharmaceuticals Ltd.TORNTPHARM | Pharmaceuticals & Biotechnology | 29,899 | 15.15 | 6.39% |
| Dr. Reddy's Laboratories Ltd.DRREDDY | Pharmaceuticals & Biotechnology | 1.24 L | 14.34 | 6.05% |
| Lupin Ltd.LUPIN | Pharmaceuticals & Biotechnology | 49,500 | 10.83 | 4.57% |
| Aurobindo Pharma Ltd.AUROPHARMA | Pharmaceuticals & Biotechnology | 56,420 | 9.69 | 4.09% |
| Fortis Healthcare Ltd.FORTIS | Healthcare Services | 1.06 L | 9.63 | 4.07% |
| Glenmark Pharmaceuticals Ltd.GLENMARK | Pharmaceuticals & Biotechnology | 30,690 | 7.61 | 3.21% |
| Alkem Laboratories Ltd.ALKEM | Pharmaceuticals & Biotechnology | 11,927 | 6.36 | 2.68% |
| Biocon Ltd.BIOCON | Pharmaceuticals & Biotechnology | 1.45 L | 5.99 | 2.53% |
| Zydus Lifesciences Ltd.ZYDUSLIFE | Pharmaceuticals & Biotechnology | 50,996 | 5.92 | 2.5% |
| IPCA Laboratories Ltd.IPCALAB | Pharmaceuticals & Biotechnology | 28,313 | 5.59 | 2.36% |
| Mankind Pharma Ltd.MANKIND | Pharmaceuticals & Biotechnology | 23,076 | 5.58 | 2.36% |
| Abbott India Ltd.ABBOTINDIA | Pharmaceuticals & Biotechnology | 1,062 | 2.75 | 1.16% |
| Piramal Pharma Ltd.PPLPHARMA | Pharmaceuticals & Biotechnology | 1.27 L | 2.72 | 1.15% |
| Syngene International Ltd.SYNGENE | Healthcare Services | 38,752 | 1.55 | 0.66% |
| TREPS | — | — | 0 | — |
| Net Current Assets | — | — | 0.03 | 0.01% |
Percentages are the AMC’s own filed figures. Rows without a ticker are instruments outside the listed equity universe — government securities, money-market paper, TREPS and net receivables — and are kept so the portfolio still totals 100%.